Susanne Isfort

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Venues

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Kailun David Zhang, Edgar Jost, Jens Panse, Reinhild Herwartz, Katharina Lindemann-Docter, Danny Jonigk, Kim Kricheldorf, Anja Köchel, Nicolas Sauerbrunn, Tim H Brümmendorf, Steffen Koschmieder, Susanne Isfort
Bone marrow biopsy in geriatric patients above the age of 85 years: invaluable or unnecessary? A retrospective analysis. Annals of hematology 103 (4) (2024)
Kailun David Zhang, Edgar Jost, Jens Panse, Reinhild Herwartz, Katharina Lindemann-Docter, Danny Jonigk, Kim Kricheldorf, Anja Köchel, Nicolas Sauerbrunn, Tim H Brümmendorf, Steffen Koschmieder, Susanne Isfort
Bone marrow biopsy in geriatric patients above the age of 85 years: invaluable or unnecessary? A retrospective analysis. Annals of hematology 103 (4) (2024)
Kailun David Zhang, Edgar Jost, Jens Panse, Reinhild Herwartz, Katharina Lindemann-Docter, Danny Jonigk, Kim Kricheldorf, Anja Köchel, Nicolas Sauerbrunn, Tim H Brümmendorf, Steffen Koschmieder, Susanne Isfort
Bone marrow biopsy in geriatric patients above the age of 85 years: invaluable or unnecessary? A retrospective analysis. Annals of hematology 103 (4) (2024)
Kailun David Zhang, Edgar Jost, Jens Panse, Reinhild Herwartz, Katharina Lindemann-Docter, Danny Jonigk, Kim Kricheldorf, Anja Köchel, Nicolas Sauerbrunn, Tim H Brümmendorf, Steffen Koschmieder, Susanne Isfort
Bone marrow biopsy in geriatric patients above the age of 85 years: invaluable or unnecessary? A retrospective analysis. Annals of hematology 103 (4) (2024)
Kailun David Zhang, Edgar Jost, Jens Panse, Reinhild Herwartz, Katharina Lindemann-Docter, Danny Jonigk, Kim Kricheldorf, Anja Köchel, Nicolas Sauerbrunn, Tim H Brümmendorf, Steffen Koschmieder, Susanne Isfort
Bone marrow biopsy in geriatric patients above the age of 85 years: invaluable or unnecessary? A retrospective analysis. Annals of hematology (2024)
Kailun David Zhang, Edgar Jost, Jens Panse, Reinhild Herwartz, Katharina Lindemann-Docter, Danny Jonigk, Kim Kricheldorf, Anja Köchel, Nicolas Sauerbrunn, Tim H Brümmendorf, Steffen Koschmieder, Susanne Isfort
Bone marrow biopsy in geriatric patients above the age of 85 years: invaluable or unnecessary? A retrospective analysis. Annals of hematology 103 (4) (2024)
Susanne Isfort, Kirsi Manz, Lino L Teichmann, Martina Crysandt, Andreas Burchert, Andreas Hochhaus, Susanne Saussele, Alexander Kiani, Joachim R Göthert, Thomas Illmer, Philippe Schafhausen, Haifa Kathrin Al-Ali, Frank Stegelmann, Mathias Hänel, Tim Pfeiffer, Aristoteles Giagounidis, Georg-Nikolaus Franke, Steffen Koschmieder, Alice Fabarius, Thomas Ernst, Mareille Warnken-Uhlich, Uta Wolber, Denise Kohn, Markus Pfirrmann, Dominik Wolf, Tim H Brümmendorf, null null
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study. Annals of hematology (2023)
Steffen Koschmieder, Susanne Isfort, Clemens Schulte, Lutz Jacobasch, Thomas Geer, Marcel Reiser, Michael Koenigsmann, Bernhard Heinrich, Jürgen Wehmeyer, Eyck von der Heyde, Hans Tesch, Benedikt Gröschl, Petra Bachhuber, Susanne Großer, Heike Luise Pahl
Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial. Annals of hematology (2023)

Susanne Isfort.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Susanne Isfort